Literature DB >> 8438577

Multiple arginine residues within the basic domain of HTLV-I Rex are required for specific RNA binding and function.

S R Hammes1, W C Greene.   

Abstract

The Rex protein of the type I human T-cell leukemia virus (HTLV-I) is essential for viral replication, acting post-transcriptionally to enhance the expression of unspliced and singly spliced viral mRNAs that encode the Gag, Pol, and Env virion proteins. Rex function involves its direct interaction with a complex stem-loop structure termed the Rex RNA response element (RexRE), which is located within the 3' retroviral long terminal repeat. Binding of Rex to the RexRE involves a positively charged arginine-rich domain located near the N-terminus which also functions as a nuclear localization signal. Strikingly, substitution of all seven of the arginine residues present within this domain with positively charged lysine residues exerted no adverse effect on the nuclear targeting of Rex. However, these lysine substitutions completely abrogated both Rex binding to the RexRE and Rex function. Reversion of multiple substituted lysines to arginines at specific locations within this domain was required to restore both RexRE binding and biological function to the Rex protein. Thus, while the presence of positive charge alone in this domain appears sufficient for nuclear localization of Rex, multiple arginine residues at specific sites are essential for the full expression of RNA binding and functional activity of this retroviral trans-regulatory protein.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8438577     DOI: 10.1006/viro.1993.1101

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  14 in total

1.  Anti-Rex aptamers as mimics of the Rex-binding element.

Authors:  S Baskerville; M Zapp; A D Ellington
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

Review 2.  The human T-cell leukemia virus Rex protein.

Authors:  Ihab Younis; Patrick L Green
Journal:  Front Biosci       Date:  2005-01-01

3.  Tax & rex: overlapping genes of the Deltaretrovirus group.

Authors:  Kathleen Margaret McGirr; Gertrude Case Buehuring
Journal:  Virus Genes       Date:  2006-06       Impact factor: 2.332

4.  Nuclear export and expression of human T-cell leukemia virus type 1 tax/rex mRNA are RxRE/Rex dependent.

Authors:  X T Bai; U Sinha-Datta; N L Ko; M Bellon; C Nicot
Journal:  J Virol       Date:  2012-02-08       Impact factor: 5.103

5.  Nucleolar and nuclear localization properties of a herpesvirus bZIP oncoprotein, MEQ.

Authors:  J L Liu; L F Lee; Y Ye; Z Qian; H J Kung
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

6.  Phosphorylation of two serine residues regulates human T-cell leukemia virus type 2 Rex function.

Authors:  M Narayan; K Kusuhara; P L Green
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

7.  Effects of translation initiation factor eIF-5A on the functioning of human T-cell leukemia virus type I Rex and human immunodeficiency virus Rev inhibited trans dominantly by a Rex mutant deficient in RNA binding.

Authors:  J Katahira; T Ishizaki; H Sakai; A Adachi; K Yamamoto; H Shida
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

8.  Human T-cell leukemia virus type 2 Rex carboxy terminus is an inhibitory/stability domain that regulates Rex functional activity and viral replication.

Authors:  Li Xie; Matthew Kesic; Brenda Yamamoto; Min Li; Ihab Younis; Michael D Lairmore; Patrick L Green
Journal:  J Virol       Date:  2009-03-11       Impact factor: 5.103

9.  Functional domain structure of human T-cell leukemia virus type 2 rex.

Authors:  Murli Narayan; Ihab Younis; Donna M D'Agostino; Patrick L Green
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

10.  Phosphorylation regulates human T-cell leukemia virus type 1 Rex function.

Authors:  Matthew Kesic; Rami Doueiri; Michael Ward; O John Semmes; Patrick L Green
Journal:  Retrovirology       Date:  2009-11-17       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.